COMPONENT 1 IS AN EPOXY RESIN PRODUCED BY THE CONDENSATION REACTION OF EPICHLOROHYDRIN AND BISPHENOL-A. THESE RAW MATERIALS ARE CONSUMED IN THE PROCESS. RESIDUAL LEVELS OF EPICHLOROHYDRIN ARE TYPICALLY 2-3 PPM IN THE PRODUCT.

THE HEALTH EFFECTS NOTED BELOW ARE CONSISTENT WITH REQUIREMENTS UNDER THE OSHA HAZARAD COMMUNICATION STANDARD (29 CFR 1910.1200).

EYE CONTACT
BASED ON SIMILAR PRODUCT TESTING PRODUCT MAY BE SEVERELY IRRITATING TO THE EYES. MAY CAUSE CORNEAL DAMAGE.

SKIN CONTACT
BASED ON HUMAN EXPERIENCE, COMPONENT 2 IS EXTREMELY IRRITATING TO THE SKIN AND MAY CAUSE SKIN DAMAGE. BASED ON HUMAN EXPERIENCE, COMPONENT 2 IS A SKIN SENSITIZER. BASED ON PRESENCE OF COMPONENT 2 PRODUCT MAY BE TOXIC IF ABSORBED.

INHALATION
BASED ON HUMAN EXPERIENCE, COMPONENT 2 MAY CAUSE IRRITATION OF THE RESPIRATORY TRACT. BASED ON COMPONENT 2 TESTING, PRODUCT MAY PRODUCE CENTRAL NERVOUS SYSTEM (CNS) DEPRESSION. ALTHOUGH NO SPECIFIC INFORMAITON IS KNOWN, BASED ON SKIN SENSITIZATION EXPERIENCE IN HUMANS, COMPONENT 2 MAY ALSO BE A RESPIRATORY TRACT SENSITIZER (SEE SIGNS AND SYMPTOMS). BECAUSE OF ITS LOW VOLATILITY, HOWEVER, SIGNIFICANT EXPOSURE BY THE INHALATION ROUTE IS UNLIKELY UNDER MOST AMBIENT CONDITIONS, BUT VAPORS, AEROSOLS, AND MISTS MAY BE FORMED DURING SOME APPLICATIONS, SEE SECTION X. BASED ON COMPONENT 2 TESTING (SEE SECTION VI), PRODUCT MAY BE MODERATELY TOXIC, MAY BE HARMFUL IF INHALED.

INGESTION
BASED ON SIMILAR PRODUCT TESTING, PRODUCT MAY BE SLIGHTLY TOXIC. BASED ON THE PRESENCE OF COMPONENT 2, PRODUCT MAY CAUSE CNS DEPRESSION.

SIGNS AND SYMPTOMS
IRRITATION AS NOTED ABOVE. SKIN SENSITIZATION (ALLERGY) MAY BE EVIDENCED BY RASHES, ESPECIALLY HIVES. RESPIRATORY TRACT SENSITIZATION (E.G., ALLERGY, ASTHMA) MAY BE EVIDENCED BY WHEEZING WITH SHORTNESS OF BREATH AND COUGH. EARLY TO MODERATE CNS DEPRESSION MAY BE EVIDENCED BY GIDDINESS, HEADACHE, DIZZINESS, AND NAUSEA; IN EXTREME CASES, UNCONSCIOUSNESS AND DEATH MAY OCCUR.

AGGRAVATED MEDICAL CONDITIONS
PREEXISTING EYE, SKIN, AND RESPIRATORY DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS PRODUCT. PREEXISTING SKIN OR RESPIRATORY TRACT ALLERGIES MAY INCREASE THE CHANCE OF DEVELOPING INCREASED ALLERGY SYMPTOMS FROM EXPOSURE TO THIS PRODUCT.

OTHER HEALTH EFFECTS
SEE SECTION VI FOR SUPPLEMENTAL HEALTH INFORMATION.

EYE CONTACT
IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER FOR AT LEAST 15 MINUTES WHILE HOLDING EYELIDS OPEN. GET MEDICAL ATTENTION.

SKIN CONTACT
IMMEDIATELY REMOVE CONTAMINATED CLOTHING OR SHOES, WIPE EXCESS FROM SKIN AND FLUSH WITH PLENTY OF WATER FOR AT LEAST 15 MINUTES. USE SOAP IF AVAILABLE OR FOLLOW BY WASHING WITH SOAP AND WATER. DO NOT REUSE CLOTHING UNTIL THOROUGHLY CLEANED. GET MEDICAL ATTENTION.

INHALATION
REMOVE VICTIM TO FRESH AIR AND PROVIDE OXYGEN IF BREATHING IS DIFFICULT. GIVE ARTIFICIAL RESPIRATION IF NOT BREATHING. GET MEDICAL ATTENTION.

INGESTION
DO NOT GIVE LIQUIDS IF VICTIM IS UNCONSCIOUS OR VERY DROWSY. OTHERWISE, GIVE NO MORE THAN 2 GLASSES OF WATER AND INDUCE VOMITING BY GIVING 30CC (2 TABLESPOONS) SYRUP OF IPECAC.* IF IPECAC IS UNAVAILABLE, GIVE 2 GLASSES OF WATER AND INDUCE VOMITING BY TOUCHING FINGER TO BACK OF VICTIM’S THROAT. KEEP VICTIM’S HEAD BELOW HIPS WHILE VOMITING. GET MEDICAL ATTENTION.

NOTE TO PHYSICIAN
* IF VICTIM IS A CHILD, GIVE NO MORE THAN 1 GLASS OF WATER AND 15CC (1 TABLESPOON) SYRUP OF IPECAC. IF SYMPTOMS SUCH AS LOSS OF GAG REFLEX, CONVULSIONS OR UNCONSCIOUSNESS OCCUR BEFORE EMESIS, GASTRIC LAVAGE SHOULD BE CONSIDERED FOLLOWING INTUBATION WITH A CUFFED ENDOTRACHEAL TUBE.

COMPONENT 1: CHRONIC STUDIES: RECENT 2-YEAR BIOASSAYS IN MICE EXPOSED BY THE DERMAL ROUTE TO SHELL EPON RESIN 828, A RESIN SIMILAR TO COMPONENT 1, THE DIGLYCIDYL ETHER OF BISPHENOL A (DGEBPA), OR TO OTHER COMMERCIAL RESINS WHICH ARE COMPOSED PREDOMINANTLY OF DGEBPA HAVE YIELDED VERY LIMITED EVIDENCE OF WEAK CARCINOGENICITY. DGEBPA IS A COMPONENT OF THIS RESIN. THE AUTHORS OF THIS WORK CONCLUDED THAT THE RENAL TUMOR EVIDENCE WITH SHELL EPON RESIN 828 "WAS OF NO BIOLOGICAL SIGNIFICANCE" AND THAT THE RESIN "IS NOT A SYSTEMIC CARCINOGEN WHEN APPLIED TO THE DORSAL SKIN OF CF1 MICE." BASED UPON THIS AND ALL OTHER AVAILABLE INFORMATION, THE INTERNATIONAL AGENCY FOR RESEARCH OF CANCER (IARC) CONCLUDED (1988) THAT DGEBPA WAS NOT CLASSIABLE AS A CARCINOGEN (IARC GROUP 3) BASED ON THE FOLLOWING: HUMAN EVIDENCE - INADEQUATE; ANIMAL EVIDENCE - INADEQUATE.

BOTH EPON RESIN 828, A RESIN SIMILAR TO COMPONENT 1 AND DGEBPA, ITS MAJOR CONSTITUENT, HAVE PROVED TO BE INACTIVE WHEN TESTED BY VIVO MUTAGENICITY ASSAYS. THEY HAVE BOTH SHOWN ACTIVITY IN VITRO MICROBIAL MUTAGENICITY SCREENING TESTS AND HAVE PRODUCED CHROMOSOMAL ABERRATIONS IN CULTURED RAT LIVER CELLS. THE SIGNIFICANCE OF THIS INFORMATION TO MAN IS UNKNOWN.

NOTE: THIS PRODUCT CONTAINS (TRACE 2-3 PPM, TYPICAL) RESIDUAL QUANTITIES OF EIPCHLOROHYDRIN (ECH), CAS NO. 106-89-8. IT IS VERY UNLIKELY THAT NORMAL WORK PRACTICES WITH THIS PRODUCT COULD RESULT IN MEASURABLE ECH CONCENTRATIONS IN THE WORKPLACE ATMOSPHERE. NEVERTHELESS, YOU SHOULD BE AWARE THAT ECH HAS BEEN REPORTED TO PRODUCE CANCER IN LABORATORY ANIMALS AND TO PRODUCE MUTAGENIC CHANGES IN BACTERIA AND CULTURED HUMAN CELLS. IT HAS BEEN CLASSIFIED BY THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC) AS A PROBABLE HUMAN CARCINOGEN (IARC GROUP 2A) BASED ON THE FOLLOWING CONCLUSIONS: HUMAN EVIDENCE - INADEQUATE; ANIMAL EVIDENCE - SUFFICIENT. IT HAS BEEN CLASSIFIED AS AN ANTICIPATED HUMAN CARCINOGEN BY THE NATIONAL TOXICOLOGY PROGRAM (NTP).

NOTE: ADDITIONAL TOXICOLOGICAL INFORMATION

COMPONENT 2: RATS EXPOSED TO N-BUTLY GLYCIDYL ETHER AT 150 PPM FOR 50 7-HOUR EXPOSURES DEMONSTRATED SIGNIFICANTLY RETARDED GROWTH. IN THE SAME STUDY, THERE WAS 50% MORTALITY IN RATS EXPOSED AT 300 PPM, WITH ADDITIONAL SIGNS OF TOXICITY IN THE SURVIVORS. TESTICULAR ATROPHY WAS OBSERVED IN RATS EXPOSED AT 300 PPM, BUT THE RATS WERE JUVENILE, OBSCURING THE SIGNIFICANCE, IF ANY, OF THE RESULT.

IN A 28 DAY INHALATION STUDY, RATS EXPOSED AT 188 PPM SHOWED DECREASED BODY WEIGHT AND CHANGES IN BLOOD CHEMISTRY. SEVERE IRRITATION OF THE UPPER RESPIRATORY TRACT WAS OBSERVED IN RATS EXPOSED AT 94 PPM AND 188 PPM.

N-BGE HAS TESTED POSITIVE IN A NUMBER OF IN VITRO GENETIC TOXICITY ASSAYS WITH AND WITHOUT METABOLIC ACTIVATION. MIXED RESULTS WERE OBSERVED IN THE DOMINANT LETHAL AND THE MOUSE MICRONUCLEUS TESTS.

SPECIAL FIRE FIGHTING PROCEDURES: CAUTION. COMBUSTIBLE. DO NOT ENTER CONFINED FIRE SPACE WITHOUT FULL BUNKER GEAR (HELMET WITH FACE SHIELD, BUNKER COATS, GLOVES AND RUBBER BOOTS), INCLUDING A POSITIVE PRESSURE NIOSH APPROVED SELF-CONTAINED BREATHING APPARATUS. COOL FIRE EXPOSED CONTAINERS WITH WATER.

UNUSUAL FIRE AND EXPLOSION HAZARDS: CONTAINERS EXPOSED TO INTENSE HEAT FROM FIRES SHOULD BE COOLED WITH WATER TO PREVENT VAPOR PRESSURE BUILDUP WHICH COULD RESULT IN CONTAINER RUPTURE. CONTAINER AREAS EXPOSED TO DIRECT FLAME CONTACT SHOULD BE COOLED WITH LARGE QUANTITIES OF WATER AS NEEDED TO PREVENT WEAKENING OF CONTAINER STRUCTURE.

RESPIRATORY PROTECTION
AVOID BREATHING VAPORS WHICH MAY BE PRODUCED UNDER SOME CONDITIONS SUCH AS HEATING OR APPLICATIONS OF UNCURED MATERIAL IN LARGE SURFACE AREAS (E.G., FLOORING AND PAINTING). AVOID BREATHING AEROSOLS AND MISTS WHICH MAY BE FORMED BY VARIOUS METHODS OF APPLICATION.

IF EXPOSURE MAY OR DOES EXCEED OCCUPATIONAL EXPOSURE LIMITS (SEC. IV) USE A NIOSH-APPROVED RESPIRATOR TO PREVENT OVEREXPOSURE. IN ACCORD WITH 29 CFR 1910.134 USE EITHER A FULL-FACE, ATMOSPHERE-SUPPLYING RESPIRATOR OR AIR -PURIFYING RESPIRATOR FOR ORGANIC VAPORS.

PROTECTIVE CLOTHING
AVOID CONTACT WITH EYES. WEAR CHEMICAL GOGGLES IF THERE IS LIKELIHOOD OF CONTACT WITH EYES. AVOID CONTACT WITH SKIN AND CLOTHING. WEAR CHEMICAL -RESISTANT GLOVES AND PROTECTIVE CLOTHING.

ADDITIONAL PROTECTIVE MEASURES
USE EXPLOSION-PROOF VENTILATION AS REQUIRED TO CONTROL VAPOR CONCENTRATIONS. EYE WASH FOUNTAINS AND SAFETY SHOWERS SHOULD BE AVAILABLE FOR EMERGENCY USE.

SPILL OR LEAK PROCEDURES
CAUTION. COMBUSTIBLE. *** LARGE SPILLS *** ELIMINATE POTENTIAL SOURCES OF IGNITION. WEAR APPROPRIATE RESPIRATOR AND OTHER PROTECTIVE CLOTHING. SHUT OFF SOURCE OF LEAK ONLY IF SAFE TO DO SO. DIKE AND CONTAIN. REMOVE WITH VACUUM TRUCKS OR PUMP TO STORAGE/SALVAGE VESSELS. SOAK UP RESIDUE WITH AN ABSORBENT SUCH AS CLAY, SAND, OR OTHER SUITABLE MATERIAL; PLACE IN NON-LEAKING CONTAINERS AND SEAL TIGHTLY FOR PROPER DISPOSAL. FLUSH AREA WITH WATER TO REMOVE TRACE RESIDUE; DISPOSE OF FLUSH SOLUTION AS ABOVE. *** SMALL SPILLS *** TAKE UP WITH AN ABSORBENT MATERIAL AND PLACE IN NON-LEAKING CONTAINERS FOR PROPER DISPOSAL.

WARNING! CONBUSTIBLE LIQUID. KEEP LIQUID AND VAPOR AWAY FROM HEAT, SPARKS AND FLAME. SURFACES THAT ARE SUFFICIENTLY HOT MAY IGNITE EVEN LIQUID PRODUCT IN THE ABSENCE OF SPARKS OR FLAME. EXTINGUISH PILOT LIGHTS, CIGARETTES AND TURN OFF OTHER SOURCES OF IGNITION PRIOR TO USE AND UNTIL ALL VAPORS ARE GONE. VAPORS MAY ACCUMULATE AND TRAVEL TO IGNITION SOURCES DISTANT FROM THE HANDLING SITE; FLASH-FIRE CAN RESULT. KEEP CONTAINERS CLOSED WHEN NOT IN USE. USE WITH ADEQUATE VENTILATION.

CONTAINERS, EVEN THOSE THAT HAVE BEEN EMPTIED, CAN CONTAIN EXPLOSIVE VAPORS. DO NOT CUT, DRILL, GRIND, WELD OR PERFORM SIMILAR OPERATIONS ON OR NEAR CONTAINERS. DO NOT PRESSURIZE DRUM CONTAINERS TO EMPTY THEM. STATIC ELECTRICITY MAY ACCUMULATE AND CREATE A FIRE HAZARD. GROUND FIXED EQUIPMENT. BOND AND GROUND TRANSFER CONTAINERS AND EQUIPMENT.

WARNING! SKIN SENSITIZER. POTENTIAL RESPIRATORY TRACT SENSITIZER. EYE AND SKIN IRRITANT. CONTAINERS, EVEN THOSE THAT HAVE BEEN EMPTIED, CAN CONTAIN HAZARDOUS PRODUCT RESIDUES. WASH WITH SOAP AND WATER BEFORE EATING, DRINKING, SMOKING, APPLYING COSMETICS OR USING TOILET FACILITIES. LAUNDER CONTAMINATED CLOTHING BEFORE REUSE. CONTAMINATED LEATHER ARTICLES, INCLUDING SHOES, CANNOT BE DECONTAMINATED AND SHOULD BE DESTROYED TO PREVENT REUSE.

THE COMPONENTS OF THIS PRODUCT ARE LISTED ON THE EPA/TSCA INVENTORY OF CHEMICAL SUBSTANCES.

PROTECTION OF STRATOSPHERIC OZONE (PURSUANT TO SECTION 6111 OF THE CLEAN AIR ACT AMENDMENTS OF 1990): PER 40 CFR PART 82, THIS PRODUCT DOES NOT CONTAIN NOR WAS IT DIRECTLY MANUFACTURED WITH ANY CLASS I OR CLASS II OZONE DEPLETING SUBSTANCES.

IN ACCORDANCE WITH SARA TITLE III, SECTION 313, THE ATTACHED ENVIRONMENTAL DATA SHEET (EDS) SHOULD ALWAYS BE COPIED AND SENT WITH THE MSDS.

THE FOLLOWING CHEMICALS ARE SPECIFICALLY LISTED BY INDIVIDUAL STATES; OTHER PRODUCT SPECIFIC HEALTH AND SAFETY DATA IN OTHER SECTIONS OF THE MSDS MAY ALSO BE APPLICABLE FOR STATE REQUIREMENTS. FOR DETAILS ON YOUR REGULATORY REQUIREMENTS YOU SHOULD CONTACT THE APPROPRIATE AGENCY IN YOUR STATE.

CA = CALIFORNIA HAZ. SUBST. LIST; CA65C, CA65R, CA65C/R = CALIFORNIA SAFE DRINKING WATER AND TOXICS ENFORCEMENT ACT OF 1986 OR PROPOSITION 65 LIST;

CT = CONNECTICUT TOXIC. SUBST. LIST; FL = FLORIDA SUBST LIST; IL= ILLINOIS TOX. SUBST. LIST; LA = LOUISIANA HAZ. SUBST. LIST; MA = MASSACHUSETTS SUBST. LIST; ME=MAINE HAZ. SUBST. LIST; MN = MINNESOTA HAZ. SUBST. LIST; NJ = NEW JERSEY HAZ. SUBST. LIST; PA = PENNSYLVANIA HAZ. SUBST. LIST; RI = RHODE ISLAND HAZ. SUBST. LIST.

NEW MSDS.

THE INFORMATION AND RECOMMENDATIONS SET FORTH HEREIN ARE TAKEN FROM SOURCES BELIEVED TO BE ACCURATE AS OF THE DATE HEREOR: HOWEVER PACE TECHNOLOGIES MAKES NO WARRANTY, EXPRESS OR IMPLIED WITH RESPECT TO THE ACCURACY OF THE INFORMATION OR THE SUITABILITY OF THE RECOMMENDATIONS, AND ASSUMES NO LIABILITY TO ANY USER THEREOF.

DATE PREPARED: 12/29/95